IDEAS home Printed from https://ideas.repec.org/p/hhb/hastba/2003_010.html
   My bibliography  Save this paper

Läkemedelsdistributionen i Norden. En komparativ studie av aktörer, resurser och aktiviteter

Author

Listed:
  • Holmberg, Christoffer

    (Dept. of Business Administration, Stockholm School of Economics)

  • Kjellberg, Hans

    (Dept. of Business Administration, Stockholm School of Economics)

  • Axelsson, Björn

    (Dept. of Business Administration, Stockholm School of Economics)

Abstract

This paper reports on a preliminary studie of the organising of pharmaceutical goods distribution in the Nordic countries. Based on close descriptions of the four national markets, Sweden, Denmark, Norway and Finland, a comparative analysis is made. The chosen comparative dimensions are: activity structures and actor constellations; vertical and horisontal integration; service levels; and pricing system. Despite their apparent similarities the four national markets display many differences in these dimensions. Further, within each national market, there are considerable differences between how the distribution operations are described in principle and how they appear when observed in practice.

Suggested Citation

  • Holmberg, Christoffer & Kjellberg, Hans & Axelsson, Björn, 2003. "Läkemedelsdistributionen i Norden. En komparativ studie av aktörer, resurser och aktiviteter," SSE/EFI Working Paper Series in Business Administration 2003:10, Stockholm School of Economics, revised 07 Aug 2003.
    • Handle: RePEc:hhb:hastba:2003_010
    as

    Download full text from publisher

    File URL: http://swoba.hhs.se/hastba/papers/hastba2003_010.pdf
    Download Restriction: no
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Mats A. Bergman & David Granlund & Niklas Rudholm, 2016. "Reforming the Swedish pharmaceuticals market: consequences for costs per defined daily dose," International Journal of Health Economics and Management, Springer, vol. 16(3), pages 201-214, September.
    2. Rudholm, Niklas, 2008. "Entry of new pharmacies in the deregulated Norwegian pharmaceuticals market--Consequences for costs and availability," Health Policy, Elsevier, vol. 87(2), pages 258-263, August.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:hhb:hastba:2003_010. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Helena Lundin (email available below). General contact details of provider: https://edirc.repec.org/data/erhhsse.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.